Picture of Sun Pharma Advanced Research logo

SPARC — Sun Pharma Advanced Research News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Sun Pharma Advanced Research Receives FDA Priority Review Voucher For Sezaby Approval

Feb 3 (Reuters) - Sun Pharma Advanced Research Co Ltd SPRC.NS:

SPARC RECEIVES FDA PRIORITY REVIEW VOUCHER FOR SEZABY APPROVAL

INTENDS TO UTILIZE VOUCHER TO FURTHER ACCELERATE ITS PIPELINE

Source text: ID:nBSEbNGrYK

Further company coverage: SPRC.NS

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Sun Pharma Advanced Research

See all news